Market cap of Zomedica Corp. [ZOM] reaches 237.80M – now what?


Zomedica Corp. [AMEX: ZOM] traded at a low on 05/06/22, posting a -1.11 loss after which it closed the day’ session at $0.24. The company report on May 4, 2022 that Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners’ Sponsorship.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced its sponsorship with the American Association of Feline Practitioners (AAFP).

“The AAFP supports feline practitioners by providing tools, guidelines and resources to assist in delivering continuing, high-quality service to their cat patients” said Larry Heaton, Zomedica’s Chief Executive Officer, “We are honored to partner with such an organization to provide a healthy future for the feline veterinary profession.”.

The results of the trading session contributed to over 15786836 shares changing hands. Over the past one week, the price volatility of Zomedica Corp. stands at 6.35% while the volatility over the past one month is 6.52%.

The market cap for ZOM stock reached $237.80 million, with 980.14 million shares outstanding and 954.09 million shares in the current float. Compared to the average trading volume of 18.03M shares, ZOM reached a trading volume of 15786836 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Zomedica Corp. [ZOM]?

The Average True Range (ATR) for Zomedica Corp. is set at 0.02, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 58.00. The Price to Book ratio for the last quarter was 0.86, with the Price to Cash per share for the same quarter was set at 0.20.

How has ZOM stock performed recently?

Zomedica Corp. [ZOM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.83. With this latest performance, ZOM shares dropped by -24.34% in over the last four-week period, additionally sinking by -58.62% over the last 6 months – not to mention a drop of -71.67% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 33.63, with the RSI for the last a single of trading hit 31.63, and the three-weeks RSI is set at 36.63 for Zomedica Corp. [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.3077, while it was recorded at 0.2431 for the last single week of trading, and 0.4179 for the last 200 days.

Zomedica Corp. [ZOM]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Zomedica Corp. [ZOM] shares currently have an operating margin of -517.14 and a Gross Margin at +46.32. Zomedica Corp.’s Net Margin is presently recorded at -444.78.

Return on Equity for this stock declined to -11.01, with Return on Assets sitting at -10.61.

Zomedica Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 45.50 and a Current Ratio set at 46.20.

Insider trade positions for Zomedica Corp. [ZOM]

There are presently around $30 million, or 14.60% of ZOM stock, in the hands of institutional investors. The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 41,635,682, which is approximately 0.437% of the company’s market cap and around 0.20% of the total institutional ownership; STATE STREET CORP, holding 28,730,202 shares of the stock with an approximate value of $6.89 million in ZOM stocks shares; and BLACKROCK INC., currently with $3.05 million in ZOM stock with ownership of nearly -29.832% of the company’s market capitalization.

Positions in Zomedica Corp. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 46 institutional holders increased their position in Zomedica Corp. [AMEX:ZOM] by around 12,983,891 shares. Additionally, 43 investors decreased positions by around 8,144,916 shares, while 33 investors held positions by with 104,449,056 shares. The mentioned changes placed institutional holdings at 125,577,863 shares, according to the latest SEC report filing. ZOM stock had 17 new institutional investments in for a total of 4,852,674 shares, while 19 institutional investors sold positions of 1,389,721 shares during the same period.